[Neytumorin as biomodular onco-therapy--allegations without documentation]

Related Experiment Video

Updated: Aug 15, 2026

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

M C Allewelt1, S P Hauser

  • 1Studiengruppe Methoden mit unbewiesener Wirksamkeit in der Onkologie, Schweizerische Krebsliga, Bern.

Praxis
|April 30, 1997
PubMed

Insights

NeyTumorin, a peptide and protein mixture from animal organs, is promoted for cancer prevention and treatment. However, scientific evidence for its efficacy and mechanism of action is lacking.

Area of Science:

  • Biotechnology
  • Immunology
  • Oncology

Context:

  • NeyTumorin is a product developed by Vitorgan-Pharmaceutical Company, based on K.E. Theurer's Cytoplasmatic Therapy.
  • It is composed of peptides and proteins from 15 different organs of fetal and young pigs and cows.
  • The therapy is indicated for cancer prevention and treatment, with costs ranging from DM 16,500 to over DM 100,000.

Purpose:

  • To evaluate the claimed efficacy and mechanism of action of NeyTumorin as a biological response modifier for cancer treatment.
  • To assess the scientific basis for the purported "hygiogenization" of disturbed metabolism and immunogenic/immuno-modulatory effects.

Summary:

  • The components of NeyTumorin are not precisely defined.
  • Preclinical data supporting direct cytostatic and immunomodulatory effects are insufficient, often using high concentrations.
  • Clinical studies, including prospective randomized trials, are inconclusive due to inadequate documentation, failing to prove the claimed mechanism or clinical efficacy.

Impact:

  • The lack of defined components and insufficient scientific evidence raises concerns about NeyTumorin's safety and effectiveness.
  • Further rigorous, well-documented research is needed to validate the therapeutic claims of NeyTumorin.
  • This analysis highlights the importance of robust scientific validation for novel cancer therapies.

More Related Videos

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma06:08

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Published on: June 2, 2023

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.